- Home
- VIGL vs ICAD Comparison
VIGL vs ICAD Comparison
Compare VIGL & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- ICAD
- Stock Information
- Founded
- VIGL 2020
- ICAD 1984
- Country
- VIGL United States
- ICAD United States
- Employees
- VIGL N/A
- ICAD N/A
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- ICAD Medical/Dental Instruments
- Sector
- VIGL Health Care
- ICAD Health Care
- Exchange
- VIGL Nasdaq
- ICAD Nasdaq
- Market Cap
- VIGL 74.7M
- ICAD 87.5M
- IPO Year
- VIGL 2022
- ICAD 1986
- Fundamental
- Price
- VIGL $1.81
- ICAD $3.24
- Analyst Decision
- VIGL Strong Buy
- ICAD Hold
- Analyst Count
- VIGL 5
- ICAD 1
- Target Price
- VIGL $16.33
- ICAD N/A
- AVG Volume (30 Days)
- VIGL 141.7K
- ICAD 1.6M
- Earning Date
- VIGL 05-06-2025
- ICAD 05-14-2025
- Dividend Yield
- VIGL N/A
- ICAD N/A
- EPS Growth
- VIGL N/A
- ICAD N/A
- EPS
- VIGL N/A
- ICAD N/A
- Revenue
- VIGL N/A
- ICAD $19,608,000.00
- Revenue This Year
- VIGL N/A
- ICAD $2.58
- Revenue Next Year
- VIGL N/A
- ICAD $14.78
- P/E Ratio
- VIGL N/A
- ICAD N/A
- Revenue Growth
- VIGL N/A
- ICAD 13.22
- 52 Week Low
- VIGL $1.31
- ICAD $1.18
- 52 Week High
- VIGL $6.06
- ICAD $3.78
- Technical
- Relative Strength Index (RSI)
- VIGL 53.10
- ICAD 72.16
- Support Level
- VIGL $1.31
- ICAD $3.00
- Resistance Level
- VIGL $1.66
- ICAD $3.38
- Average True Range (ATR)
- VIGL 0.16
- ICAD 0.18
- MACD
- VIGL 0.06
- ICAD 0.19
- Stochastic Oscillator
- VIGL 97.24
- ICAD 96.18
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.